Nhận Dạng Quốc Tế & Đặc Tính Hóa Học
Monoisotopic mass
380.199902243
InChI
InChI=1S/C21H29FO5/c1-18-7-5-13(24)9-12(18)3-4-15-14-6-8-20(27,17(26)11-23)19(14,2)10-16(25)21(15,18)22/h9,14-16,23,25,27H,3-8,10-11H2,1-2H3/t14-,15-,16-,18-,19-,20-,21-/m0/s1
InChI Key
InChIKey=AAXVEMMRQDVLJB-BULBTXNYSA-N
IUPAC Name
(1R,2S,10S,11S,14R,15S,17S)-1-fluoro-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one
Traditional IUPAC Name
fludrocortisone
SMILES
[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Độ hòa tan
140 mg/L (at 25 °C)
pKa (strongest acidic)
12.55
pKa (Strongest Basic)
-3.3
Refractivity
96.93 m3·mol-1
Dược Lực Học :
Fludrocortisone is a synthetic adrenocortical steroid possessing very potent mineralocorticoid properties and high glucocorticoid activity. It is indicated as partial replacement therapy for primary and secondary adrenocortical insufficiency in Addison’s disease and for the treatment of salt-losing adrenogenital syndrome. The physiologic action of fludrocortisone acetate is similar to that of hydrocortisone. However, the effects of fludrocortisone acetate, particularly on electrolyte balance, but also on carbohydrate metabolism, are considerably heightened and prolonged. Mineralocorticoids act on the distal tubules of the kidney to enhance the reabsorption of sodium ions from the tubular fluid into the plasma; they increase the urinary excretion of both potassium and hydrogen ions.
Cơ Chế Tác Dụng :
A synthetic mineralocorticoid with anti-inflammatory activity. [PubChem]
Fludrocortisone binds the mineralocorticoid receptor (aldosterone receptor). This binding (or activation of the mineralocorticoid receptor by fludrocortisone) in turn causes an increase in ion and water transport and thus raises extracellular fluid volume and blood pressure and lowers potassium levels.
Dược Động Học :
▧ Protein binding :
High
▧ Metabolism :
Hepatic, some renal.
▧ Half Life :
3.5 hours
Độc Tính :
Effects of overexposure include irritation, cardiac edema, increased blood volume, hypertension, cardiac arrhythmias, enlargement of the heart, headaches, and weakness of the extremities.
Chỉ Định :
For partial replacement therapy for primary and secondary adrenocortical insufficiency in Addison's disease and for the treatment of salt-losing adrenogenital syndrome.
Tương Tác Thuốc :
-
Acenocoumarol
The corticosteroid, fludrocortisone, alters the anticoagulant effect, acenocoumarol.
-
Acetylsalicylic acid
The corticosteroid, fludrocortisone, may decrease the effect of the salicylate, acetylsalicylic acid.
-
Ambenonium
The corticosteroid, fludrocortisone, may decrease the effect of the anticholinesterase, ambenonium.
-
Amobarbital
The barbiturate, amobarbital, may decrease the effect of the corticosteroid, fludrocortisone.
-
Anisindione
The corticosteroid, fludrocortisone, alters the anticoagulant effect of anisindione.
-
Aprobarbital
The barbiturate, aprobarbital, may decrease the effect of the corticosteroid, fludrocortisone.
-
Bismuth Subsalicylate
The corticosteroid, fludrocortisone, may decrease the effect of the salicylate, bismuth subsalicylate.
-
Butabarbital
The barbiturate, butabarbital, may decrease the effect of the corticosteroid, fludrocortisone.
-
Butalbital
The barbiturate, butalbital, may decrease the effect of the corticosteroid, fludrocortisone.
-
Butethal
The barbiturate, butethal, may decrease the effect of the corticosteroid, fludrocortisone.
-
Dicoumarol
The corticosteroid, fludrocortisone, alters the anticoagulant effect of dicumarol.
-
Dihydroquinidine barbiturate
The barbiturate, dihydroquinidine barbiturate, may decrease the effect of the corticosteroid, fludrocortisone.
-
Edrophonium
The corticosteroid, fludrocortisone, may decrease the effect of the anticholinesterase, edrophonium.
-
Ethotoin
The enzyme inducer, ethotoin, may decrease the effect of the corticosteroid, fludrocortisone.
-
Fosphenytoin
The enzyme inducer, fosphenytoin, may decrease the effect of the corticosteroid, fludrocortisone.
-
Heptabarbital
The barbiturate, heptabarbital, may decrease the effect of the corticosteroid, fludrocortisone.
-
Hexobarbital
The barbiturate, hexobarbital, may decrease the effect of the corticosteroid, fludrocortisone.
-
Magnesium salicylate
The corticosteroid, fludrocortisone, may decrease the effect of magnesium salicylate.
-
Mephenytoin
The enzyme inducer, mephenytoin, may decrease the effect of the corticosteroid, fludrocortisone.
-
Methohexital
The barbiturate, methohexital, may decrease the effect of the corticosteroid, fludrocortisone.
-
Methylphenobarbital
The barbiturate, methylphenobarbital, may decrease the effect of the corticosteroid, fludrocortisone.
-
Midodrine
Increased arterial pressure
-
Neostigmine
The corticosteroid, fludrocortisone, may decrease the effect of the anticholinesterase, neostigmine.
-
Pentobarbital
The barbiturate, pentobarbital, may decrease the effect of the corticosteroid, fludrocortisone.
-
Phenobarbital
The barbiturate, phenobarbital, may decrease the effect of the corticosteroid, fludrocortisone.
-
Phenytoin
The enzyme inducer, phenytoin, may decrease the effect of the corticosteroid, fludrocortisone.
-
Primidone
The barbiturate, primidone, may decrease the effect of the corticosteroid, fludrocortisone.
-
Pyridostigmine
The corticosteroid, fludrocortisone, may decrease the effect of the anticholinesterase, pyridostigmine.
-
Quinidine barbiturate
The barbiturate, quinidine barbiturate, may decrease the effect of the corticosteroid, fludrocortisone.
-
Rifampicin
The enzyme inducer, rifampin, may decrease the effect of the corticosteroid, fludrocortisone.
-
Salicylate-sodium
The corticosteroid, fludrocortisone, may decrease the effect of the salicylate, salicylate-sodium.
-
Salsalate
The corticosteroid, fludrocortisone, may decrease the effect of the salicylate, salsalate.
-
Secobarbital
The barbiturate, secobarbital, may decrease the effect of the corticosteroid, fludrocortisone.
-
Tacrine
Tacrine and Fludrocortisone may independently exacerbate muscle weakness in myasthenia gravis patients. Monitor for additive muscle weakness effects.
-
Talbutal
The barbiturate, talbutal, may decrease the effect of the corticosteroid, fludrocortisone.
-
Trastuzumab
Trastuzumab may increase the risk of neutropenia and anemia. Monitor closely for signs and symptoms of adverse events.
-
Trisalicylate-choline
The corticosteroid, fludrocortisone, may decrease the effect of the salicylate, trisalicylate-choline.
-
Vecuronium
Vecuronium may increase the adverse neuromuscular effects of systemic corticosteroids, such as Fludrocortisone. Monitor for increased muscle weakness and signs of polyneuropathies and myopathy.
-
Warfarin
The corticosteroid, fludrocortisone, alters the anticoagulant effect of warfarin.
Liều Lượng & Cách Dùng :
Tablet - Oral
Dữ Kiện Thương Mại
Nhà Sản Xuất
-
Sản phẩm biệt dược : Adixone
-
Sản phẩm biệt dược : Astonin
-
Sản phẩm biệt dược : Cortineff
-
Sản phẩm biệt dược : Florinef Acetaat
-
Sản phẩm biệt dược : Florinefe
-
Sản phẩm biệt dược : Fludrocortison
-
Sản phẩm biệt dược : Lonikan
Tài Liệu Tham Khảo Thêm
National Drug Code Directory